Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Acyclovir in Viral Uveitis
NCT03389191Unknown
- Start
- Jan 2017
- Primary completion
- Dec 2019
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Open-label, single-arm trial of aciclovir in Viral Uveitis. Primary endpoint: Mean and median change in best corrected visual acuity in logMAR at 12 weeks. Status: unknown.
02
Drugs
aciclovir
03
Conditions
Viral Uveitis
Beyond the preview
Go deeper on NCT03389191.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03389191.